The clinical forms of leprosy constitute a spectrum that correlates closely with the degree of cellmediated immunity. Patients with tuberculoid leprosy develop strong cell-mediated responses and have only a few, localized lesions, whereas patients with multibacillary lepromatous leprosy are specifically unresponsive to antigens of Myobacterium leprae. T cells of the CD4+ subset predominate in tuberculoid lesions, whereas CD8+ cells predominate in lepromatous lesions. Monoclonal antibodies that distinguish subpopulations of CD4+ and CD8+ cells were used to analyze the distribution of T cells infiltrating lesions across the disease spectrum. In lepromatous lesions, T cells of T-suppressor phenotype (9.3-) were the predominant CD8+ cells and suppressor/inducer cells (2H4+, Leu-8+) represented half of the CD4+ subset. In tuberculoid lesions, helper T cells (CD4+4B4+) outnumbered suppressor/inducer T cells by 14:1, compared with a ratio of 1.2:1 in peripheral blood. Analysis of the precursor frequency of antigen-reactive T cells permitted us to estimate that there was a 100-fold enrichment of T cells able to proliferate in response to M. leprae antigens in tuberculoid lesions (2/100), when compared with blood from the same patients. The methods used here to characterize the T-lymphocyte subsets and frequency of antigen-reactive T cells in leprosy may be useful in analyzing imunological reactions occurring in lesions of other inflammatory and autoimmune diseases.
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There are at least two compelling reasons to study leprosy. The disease itself, affecting 10-15 million people worldwide, poses a significant health and economic burden on thirdworld countries. Second, because leprosy is a spectral disease in which pathology and immunology are inextricably related, it provides a unique critical model for investigating immunoregulatory mechanisms in humans.
Leprosy is not a single critical entity but rather comprises a spectrum of clinical manifestations that correlate remarkably well with immunological responses to the organism (1) . Patients with tuberculoid leprosy have a few localized lesions with rare organisms and a strong cell-mediated immune response directed against Myobacterium leprae antigens that ultimately kills and clears the bacilli, although often with concomitant injury to nerves. In contrast, lepromatous leprosy patients have numerous skin lesions containing extraordinarily high numbers of acid-fast bacilli and show specific immunological unresponsiveness to antigens of M. leprae in vivo and in vitro.
The selective mechanisms of accumulation of lymphocytes, their antigen specificity, and immunological functions in inflammatory lesions of human infectious or autoimmune diseases remain largely unknown. Since the focal point of the immune response to M. leprae is the tissue granuloma, consisting of a collection of lymphocytes and macrophages, some of these questions can be approached directly through the study of cells infiltrating the lesions across the spectrum of leprosy.
Immunohistological studies using monoclonal antibodies to characterize T-lymphocyte subsets in granulomas revealed striking differences in the various types of leprosy (2, 3) . Tuberculoid (TT and BT) lesions contain a predominance of T cells of the CD4+ helper/inducer subset, whereas lepromatous lesions contain mainly T cells of the CD8+ suppressor/cytotoxic subset in proportions quite distinct from the normal peripheral blood CD4+/CD8+ ratio (4).
The CD4+ subset has recently been further divided into immunoregulatory subpopulations by a series of monoclonal antibodies (5, 6, 11, 17, 18) . The 2H4-4B4+ subset has been shown to proliferate in response to soluble antigens and to enable B cells to produce immunoglobulin and is thought to comprise helper T cells. The suppressor/inducer subpopulation of CD4 + cells has been reported to express the 2H4+4B4-(5) and/or Leu-8+ (17, 18) surface markers. In addition, the CD8+ subset has been divided into reciprocal immunoregulatory subsets with the suppressor T-cell subset being CD8+9.3-CD11+ and the cytotoxic T-cell subset being CD8 +9.3 + CD11-(7). Because CD4 + and CD8 + cells are present in varying proportions in lesions across the spectrum of leprosy, it was of interest to explore differences in the immunoregulatory T-cell populations in cellular reactions of leprosy lesions.
Although phenotyping of lymphocytes in leprosy lesions has provided important information about the nature of cells present in the inflammatory sites, the delineation of the immune function of these cells is of potentially greater interest. We recently developed methods for isolating lymphocytes directly from lesions (4, 8) . In the present study, CD4 + T cells were isolated from lesions across the spectrum of leprosy and characterized with respect to their surface markers and antigen reactivity. Using a limiting-dilution analysis to estimate the precursor frequency of antigenreactive T cells, we were able to demonstrate the enrichment of antigen-specific CD4+ T cells in specific inflammatory lesions relative to peripheral blood. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. loid and 7 untreated lepromatous patients were studied for reactivity of cells extracted from lesions.
MATERIALS AND METHODS
Tissues. A portion of an ellipsoidal skin biopsy specimen was quick-frozen for immunostaining as described (9) , and the remainder was transported to the laboratory for extraction of lymphocytes (4, 8) .
Monoclonal Antibodies. Primary mouse monoclonal antibodies were used at concentrations predetermined by titrations on cells from reactive tonsils. Anti-2H4 (Coulter) was used at a 1:50 dilution, anti-B4 (Coulter) at 1:400, anti-Leu-8 (Becton Dickinson) at 1:100, and anti-9.3 (John A. Hansen, Seattle) at 1:300, but the anti-CD11 marker Leu-15 (anti-CR3, Becton Dickinson) did not provide adequate tissue staining. Each specimen was additionally stained with anti-CD3, which recognizes a pan-T-cell marker (Leu-4, 1:200); anti-CD4, which identifies the helper/inducer T-cell subset (Leu-3a, 1:25); and anti-CD8, which identifies the suppressor/cytotoxic T-cell subset (Leu-2a, 1:50).
Immunoperoxidase Staining. Indirect single immunoperoxidase staining and double immunostaining techniques have been reported in detail (9) . Double staining was performed on all specimens pairing anti-2H4 or anti-Leu-8 with anti-Leu-3a and anti-9.3 with anti-Leu-2a. (Anti-4B4 was not satisfactory for the double staining method.) The immunoperoxidase reaction yielded a red product from 3-amino-9-ethylcarbazole in the presence of hydrogen peroxide. The glucose oxidase system (Vectastain kit, Vector Laboratories, Burlingame, CA) produced a blue color with the substrate nitro blue tetrazolium.
Quantitation of Stained Cells. Percent single-or doublestaining cells was determined as previously described (9) . Double-stained cells were identified when both red and blue colors could be seen on the same cell or when a purple color was present.
The percent of Leu-3a+ cells staining with anti-2H4+ or anti-Leu-8 could be calculated as the number of doublestained cells counted divided by the total number of Leu-3a+ (single-or double-staining) cells counted. This ratio was multiplied by the precent Leu-3a+ to give the percentage that were CD4+2H4+. The CD4+2H4 -phenotype was calculated as the percent Leu-3a+ minus percent CD4+-2H4+ . CD8+ subpopulations were similarly calculated using double staining with anti-9.3.
Peripheral Blood Cells. PBMCs were separated by FicollHypaque centrifugation from 10 tuberculoid and 8 lepromatous patients. Cells were stained simultaneously with fluorescein-isothiocyanate-conjugated anti-T4 (Coulter) and phycoerythrin-labeled anti-2H4 (Coulter) or anti-4B4 and analyzed by flow cytometry.
Extraction of Lymphocytes from Biopsy Specimens. Lymphocytes were extracted from skin specimens as previously reported in detail (4) and then labeled with fluorescein isothiocyanate-conjugated monoclonal antibodies anti-CD4 (T4, Coulter) and anti-CD8 (T8, Coulter) and phycoerythrinconjugated 2H4 and 4B4. Cell populations were then analyzed and sorted to >90% purity by flow cytometry.
Lines from Tissue-Extracted Lymphocytes. CD4+ cells were expanded and maintained with interleukin 2 (IL-2; Electro-Nucleonics, Oak Ridge, TN) by seeding 1000 cells per well in the presence of lethally irradiated (3000 rads; 1 rad = 0.01 Gy) autologous or HLA-DR-matched peripheral blood mononuclear cells (PBMCs) as feeders (8) . Some Several experimental observations in our leprosy patients support the claim that the CD4+4B4' subset approximates the CD4+2H4-subset: (i) measurement of the CD4+4B4+/CD4+2H4+ ratio by sorting of cells extracted from two tuberculoid and two lepromatous biopsy specimens gave results identical to the CD4+2H4 -/CD4+2H4+ ratio measured by immunoperoxidase in the tissue sections from the same biopsy specimens; (it) of the CD4+2H4-cells sorted from the peripheral blood of leprosy patients, more than 90o were found to be positive for 4B4; and (iii) the cells morphologically identifiable as lymphocytes located in the core of the tuberculoid granuloma that were CD4+2H4 were also positive for 4B4.
Our analysis indicates that the ratio of CD4 +4B4+ (helper/inducer) cells to CD4+2H4+ (suppressor/inducer) cells was 14:1 in tuberculoid lesions and 1.1:1 in lepromatous lesions. In contrast, the ratio of CD4+4B4+ cells to CD4+2H4' cells in peripheral blood was 1.2:1 in tuberculoid patients and 1.9:1 in lepromatous patients (Fig. 2) . The distribution of CD8 + subpopulations was investigated in leprosy lesions by using the monoclonal antibody anti-9.3 (7). Cells positive for the 9.3 antigen were present throughout all types of granulomas and comprised 16% of the cells in lepromatous lesions and 38% of the cells in tuberculoid lesions. In lepromatous lesions, the CD8 +9.3 -subset, reported to be a T-suppressor subset, predominated; in tuberculoid lesions, the CD8+9.3+ subset, reported to comprise cytotoxic T cells, was the predominant CD8+ subpopulation (Fig. 2) .
IL-2-Dependent T-Cefl Lines from Leprosy Lesions. To ascertain whether cells of the helper phenotype present in the lesions were antigen-specific and activated in situ, CD4 + or CD4+4B4+ cells were extracted from lesions and established as T-cell lines in vitro by culture in the presence of IL-2 alone. Our reasoning was that by expanding all T cells activated in situ to express the IL-2 receptor (Tac), rather than selecting initially with antigen, we could establish whether a significant percentage of the Tac+ cells was specifically responsive to M. leprae antigens. All the T-cell lines from tuberculoid leprosy lesions established in this manner were found to be CD3+CD4+CD8-DR+ Tac + 2H4 -4B4 . Seven such lines were found to be antigen-specific and proliferated in response to M. leprae and, to a variable extent, to M. tuberculosis but not in response to tetanus toxoid (Fig. 3) Determination of Precursor Frequency of M. lepraeReactive Lymphocytes. Although differences in the percentage of the CD4+ subsets of patients with tuberculoid leprosy were found in the blood versus lesions, we wished to know if there was a difference in the percentage of lymphocytes responsive to M. leprae. This was investigated by performing limiting-dilution analysis of precursor frequencies of M. leprae-reactive cells (Fig. 4) . We observed that in tuberculoid lesions, -2% of T cells proliferated in response to M. leprae compared with :0.02% in the peripheral blood of tuberculoid patients and patient contacts. There is thus as much as a 100-fold greater concentration of M. lepraereactive T-lymphocytes in the lesion as compared to the peripheral blood.
DISCUSSION
We have attempted to combine immunohistologic techniques to determine the phenotype of lymphocyte populations infiltrating lesions of leprosy together with functional studies of T cells in order to investigate the pathogenesis of Immunohistologic studies revealed that the core of the granuloma is composed of well-differentiated macrophages microanatomically apposed with T cells of a helper (CD4+4B4+2H4-) phenotype (6) . When T-cell lines were established from these cells, they proliferated in response to M. leprae and produced interferon y, characteristic of T helper cells in cell-mediated immunity. The outer mantle of the tuberculoid granuloma contains CD8+ cells of both cytotoxic (9.3+) and suppressor (9.3 -) phenotypes. In addition there are CD4+ lymphocytes bearing the 2H4 and Leu-8 markers. Since most individuals infected with M. leprae develop no signs of clinical disease, it is not surprising to find cells of the suppressor/inducer and suppressor phenotypes in lesions of tuberculoid patients, who have not fully resisted the pathogen. Since this type of lesion is generally self-limited, the predominant T helper and cytotoxic cells may limit the granuloma, albeit often at the cost of some nerve and tissue damage.
The lepromatous granuloma consists of a preponderance of CD8+ cells with a CD4+/CD8+ ratio of 0.6:1 in tissue lesions as compared to 2:1 found in peripheral blood (4) . Macrophages laden with bacilli are closely associated with both CD4 + and CD8 + subsets in the lesions. We established CD8 + lines and clones from lepromatous lesions and showed that these cells function in vitro as antigen-specific T suppressor cells and are restricted by class II histocompatibility antigens (4, 8) . Similar findings of peripheral blood T-suppressor cells in leprosy patients have been reported by Ottenhoff et al. (12) and Kikuchi et al. (13) . In the present study, it is clear that half of the CD4+ cells in the lepromatous lesions are 2H4 + and Leu-8 , consistent with a suppressor/inducer function. Furthermore, the predominant CD8 + cell was 9.3 -(that is, of the suppressor T-cell subset). Yet CD4+4B4+ lines and clones from lepromatous lesions failed to respond to M. leprae, even when supplemented with IL-2 or with antigen plus IL-2. These data suggest that CD8+ suppressor cells may contribute, over a prolonged period of time in this chronic disease, to the functional depletion of M. leprae-reactive CD4 + lymphocytes from the immunologic repertoire of lepromatous patients. One must be cautious, however, in imputing functional significance to T-cell subsets defined solely by reactivity with monoclonal antibodies to 4B4, 2H4, Leu-8, and 9. 
